MALDI-TOF BioMérieux Gets FDA 510(k) Clearance for MALDI-TOF Bacterial ID System The next-generation system, which received CE marking last year, identifies bacteria more rapidly and is now commercially available in the US. MALDI-TOF Mass Spec Approach Can Predict Antimicrobial Resistance in Clinical Samples A Swiss team said the mass spectrometry- and machine learning-based approach could help guide clinical treatment choices. Agena Bioscience Gets FDA Emergency Use Authorization for MassArray Coronavirus Test The company's RT-PCR/MALDI-TOF test comprises five assays designed to detect the N, ORF1, and ORF1ab regions of the SARS-CoV-2 genome. At ASMS 2017, Vendors Focus on Software, Applications Premium With the exception of Thermo Fisher Scientific, which released three new instruments, vendors focused mainly on expanded applications of existing platforms. MALDI-Based Fatty Acid Profiling Offers Infectious Disease Dx Potential Premium Scientists from the Colorado School of Mines have proposed a method to complement mass spec-based protein profiling. Jan 15, 2016 Emerging Proteomic Technologies: MALDI-TOF for Clinical Protein Quantitation Premium May 14, 2015 Map Diagnostics Developing Mass Spec Test for Down Syndrome Premium Apr 29, 2015 Swedish Researchers Use MALDI-TOF to Type Clostridium Difficile Jul 19, 2013 MALDI Mass Spec Poised for Further Expansion into Clinical Microbiology Market Pending FDA Approvals Premium Jan 28, 2013 Ezose Sciences, Kyowa Hakko Ink Glycomics Pact Jan 3, 2013 Bruker Licenses IP from Erasmus Medical Center Mar 2, 2012 Biodesix Inks Deal to Test Veristrat in Phase III Clinical Trial for Kadmon Lung Cancer Drug Premium Jan 20, 2012 New Instruments, Applications Powering Rise of MALDI-MS as Clinical Proteomics Platform Premium Dec 9, 2011 Glycomics Firm Ezose Inks Deal with Merck for Diabetes Biomarker Work Premium Dec 1, 2011 Bruker, Chungnam National University Partner on Glycan Analysis Aug 26, 2011 Bio-Rad Develops More Sensitive, Streamlined Workflow for SPR-Mass Spec Premium Aug 19, 2011 Proteomics Technologies Making Their Way into Pathogen Detection Premium May 6, 2011 Michigan Researchers ID Potential Glycoprotein Biomarker for Pancreatic Cancer Premium Apr 8, 2011 Top-Down Proteomics Inching Its Way Toward the Mainstream Premium Jan 21, 2011 Q&A: Oncologist Cristobal Belda-Iniesta on Proteomics' Role in Improving Cancer Treatments Premium Nov 5, 2010 Q&A: Metropolitan Museum of Art's Julie Arslanoglu on Proteomics in Art History and Conservation Premium Dec 3, 2009 Germany's Synlab to Use Bruker Mass Spec Tech for Microbial Identification Breaking News Bio-Rad Laboratories, Cytek Biosciences Partner on Flow Cytometry Reagents Tecan Inks Deals for NGS Library Prep System With Element Biosciences, Singular Genomics Genomenon, Flagship Biosciences Partner on Biomarker Discovery, Companion Dx Development Velsera to Integrate Arima Genomics Gene Fusion Test in Pierian Clinical Platform Evonetix Raises $24M in Extended Series B Funding Round The Scan Study Points to Tuberculosis Protection by Gaucher Disease Mutation A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds. SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource. Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages. UK Team Presents Genetic, Epigenetic Sequencing Method Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.